![]() |
|
|
Vol. 29, Issue 1, 17-22, January 2001
Department of Pharmacology (S.R.M., M.B.S., S.S.K., E.T.M.) and Program in Molecular Therapeutics and Toxicology, Graduate Division of Biological and Biomedical Sciences (S.R.M., M.B.S.), Emory University, Atlanta, Georgia
| |
Abstract |
|---|
|
|
|---|
Acute treatment of rats with bacterial endotoxin or particulate
irritants induces the expression of CYP4A mRNAs in rat liver and
kidney. To determine whether all or part of these effects could be
caused by hypophagia associated with the treatments, we pair-fed
saline-injected rats to rats injected with endotoxin or the particulate
irritant BaSO4. The effects of endotoxin on hepatic or
renal CYP4A1, CYP4A2, or CYP4A3 expression 24 h after injection
were clearly distinguishable in kinetics and magnitude from those of
pair feeding, indicating that the effects of endotoxin are not caused
by hypophagia. Conversely, BaSO4 treatment caused a more
profound hypophagia, and pair feeding to these animals produced effects
similar to those of the irritant treatment, indicating that CYP4A
induction by BaSO4 is mainly caused by reduced food intake.
To gain further insight into the mechanism of induction of CYP4A by
these inflammatory agents, we studied the sex dependence of their
effects in Fischer 344 and Sprague-Dawley rats. No significant strain
differences were observed, but the induction of hepatic CYP4A mRNAs by
endotoxin or BaSO4 was either absent in females or
significantly lower than in males. This sex specificity of induction of
hepatic CYP4As has been reported previously for peroxisome proliferators, and thus our results are consistent with a role for the
peroxisome proliferator-activated receptor-
in the induction of
hepatic CYP4As by inflammatory agents.
| |
Introduction |
|---|
|
|
|---|
Members
of the CYP4A subfamily of cytochrome P450 (P4501)
enzymes catalyze the
- and
-1-hydroxylation of fatty acids,
including arachidonic acid, as well as arachidonic acid epoxidations
(Nguyen et al., 1999
). Expression of CYP4As in rodent livers and
kidneys is induced by peroxisome proliferators (Sharma et al., 1989
)
and by physiological states such as diabetes or starvation in which fatty acid levels are elevated (Imaoka et al., 1990
; Shimojo et al.,
1993
; Kroetz et al., 1998
). Fatty acids and peroxisome proliferators bind to and activate peroxisome proliferator-activated receptor (PPAR)
, a member of the steroid hormone receptor superfamily (Wahli
et al., 1999
). PPAR
binds as a heterodimer with the retinoid X
receptor to enhancer elements on responsive genes, including the CYP4As
(Johnson et al., 1996
), resulting in their transcriptional activation.
The in vivo induction of CYP4A mRNAs by chemicals, starvation, or
diabetes requires PPAR
, since mice lacking this receptor fail to
respond to the respective stimuli (Lee et al., 1995
; Kroetz et al.,
1998
).
CYP4A mRNAs are induced in the livers and kidneys of rats during
inflammation and infection (Sewer et al., 1997
), unlike most other
hepatic P450 gene products, which are down-regulated (Morgan, 1997
;
Sewer et al., 1997
). CYP4A mRNAs are also induced in the kidneys of
female mice by treatment with bacterial lipopolysaccharide (LPS)
treatment, and this effect is absent in PPAR
-null mice, indicating
that the renal induction is PPAR
-dependent (Barclay et al., 1999
).
However, CYP4A mRNAs are down-regulated in female mouse liver after LPS
treatment (Barclay et al., 1999
), and therefore the participation of
PPAR
in hepatic CYP4A induction by inflammation in the rat remains
to be elucidated. To gain further insight into this question, in the
present study we examined the sex dependence of induction of CYP4As by
inflammatory stimuli in the rat. A characteristic feature of hepatic
CYP4A induction by peroxisome proliferators in this species is a
pronounced sex difference (females are refractory) (Sundseth and
Waxman, 1992
).
Our previous work showing induction of renal and hepatic CYP4A mRNAs by
inflammatory stimuli was conducted in Fischer 344 (F344) rats (Sewer et
al., 1997
). However, we also reported that hepatic induction of CYP4A2
mRNA by LPS treatment was absent in Sprague-Dawley (S-D) rats and that
the hepatic induction of CYP4A1 and CYP4A3 mRNAs in this strain was
attenuated relative to the effect seen in F344 rats (Sewer et al.,
1997
). Because a significant strain difference could be a potential
tool to address the mechanism of CYP4A induction, a second goal of this
study was to solidify this preliminary observation and to determine
whether such a strain difference was restricted to LPS as the
inflammatory stimulus.
As noted above, CYP4As are induced by starvation in a PPAR
-dependent
manner. LPS causes a reduction in food intake in mice (Kozak et al.,
1994
), but this hypophagia is not responsible for the induction of
renal CYP4A by LPS because mice pair-fed with LPS-treated
animals did not demonstrate renal CYP4A induction (Barclay et al.,
1999
). However, this observation did not rule out the possibility that
hypophagia could contribute to induction of hepatic CYP4As in the rat,
and the role of hypophagia in the response to particulate irritants has
not been investigated. The present study addresses these questions as
well. Our results are consistent with a sex-specific, PPAR
-mediated
induction of CYP4A mRNAs in rat liver, but the previously reported
strain difference was not detected. We found that the induction of
CYP4A expression by LPS in the rat is not caused by hypophagia, whereas
the effect of the particulate irritant BaSO4
appears to be mainly via an effect on the animals' feeding behavior.
| |
Materials and Methods |
|---|
|
|
|---|
Animals and Treatments.
All procedures were approved by the Institutional Animal Care and Use
Committee of Emory University. Male or female S-D or F344 rats (Harlan
Inc., Indianapolis, IN) were allowed to acclimatize to the Animal Care
Facility for at least one week after delivery, before treatment. They
were 8 to 10 weeks old at the time of injection. Rats received a single
i.p. injection of either 1 mg/kg (0.15 mg/ml) chromatographically pure
Escherichia coli LPS, serotype 0127:B8 (Sigma, St. Louis,
MO), dissolved in sterile 0.9% saline; 3 g/kg (0.45 mg/ml)
BaSO4 suspended in saline; or an equivalent volume of vehicle. We have shown that this dose of LPS produces a
maximal suppression of total P450 and CYP2C11 content in rat liver
(Morgan 1989
) and induces CYP4A expression in rat liver and kidney
(Sewer et al., 1996
, 1997
). The dose of BaSO4
used was optimized previously for maximal CYP4A induction (Sewer et al., 1997
). Animals were sacrificed by CO2
asphyxiation 24 h after injection. Tissues were harvested and used
immediately or flash-frozen in liquid nitrogen and stored at
80°C.
RNA Preparation and Northern Blotting.
Total RNA was prepared from fresh or frozen liver or kidney by
acid-phenol extraction (Chomczynski and Sacchi, 1987
). Samples were
stored at
80°C until analysis. RNA concentrations were determined by absorbance at 260 nm. For Northern blot assays, RNA was fractionated on a 1% agarose gel electrophoresis in the presence of 5%
formaldehyde and transferred to nylon transfer membrane filters
(Sambrook et al., 1989
) (MagnaGraph, Micron Separations, Inc.,
Westboro, MA). Blots were prehybridized, hybridized, and washed as
described below. The amount of probe bound to the filter was
quantitated using a Molecular Dynamics (Sunnyvale, CA) 445si
phosphorimager and ImageQuant software. Results were normalized to the
content of glyceraldehyde-3-phosphate dehydrogenase (GAP) mRNA or rRNA using the probes described below.
Probes and Hybridization Conditions.
The mRNAs for CYP4A1, -4A2, and -4A3 were detected using custom
synthesized oligonucleotide probes (Life Technologies Inc., Rockville,
MD) designed to recognize regions of the 3'-untranslated regions of
their mRNAs that have low sequence similarity. Thus, the CYP4A1 and
CYP4A3 probes (Fig. 1) are complementary
to a region of their mRNAs that is expressed as part of exon 12 but
which is recognized as an intron, spliced, and removed in CYP4A2
(Helvig et al., 1998
). The CYP4A2 probe spans this intron and
therefore is specific for this mRNA (Fig. 1). The sequences of the
probes were as follows: CYP4A1,
5'-GGTATGGGAAGGGTGCTGGCTTTAAAGCAGAGGAATATTC-3'; CYP4A2,
5'-ACACACACAAGCTGGGAAGGTGTCTGGAGTAAAAGCTTTGG-3'; and CYP4A3, 5'-AATTAGCCAGTAACAAATGCAGGTATTGCAGGCAGCAGAC-3'. CYP4A1 mRNA was also
detected using the 3' SacI-EcoRI fragment of its
cDNA (GenBank accession no. X07259; Earnshaw et al., 1988
).
Fibrinogen
-chain and GAP mRNAs were detected using their respective
cDNAs. The fibrinogen
-cDNA was kindly donated by Dr. Gerald
Fuller (University of Alabama at Birmingham, Birmingham, AL); the GAP
cDNA was purchased from the American Type Culture Collection (Manassas,
VA). Rat 28S rRNA was detected using an oligonucleotide probe (Barbu
and Dautry, 1989
).
|
-[32P]ATP using T4-polynucleotide kinase.
The CYP4A2 and rRNA oligonucleotides were hybridized overnight at
50°C in 1× SSPE buffer (10 mM sodium phosphate, pH 7.7, containing 0.18 M NaCl and 1 mM EDTA); 1 mM EDTA, 0.5% SDS, 0.1 mg/ml
yeast tRNA; and 5× Denhardt's solution (Sambrook et al., 1989
-[32P]dCTP by
random primer labeling (Megaprime, Amersham, Arlington Heights,
IL). Blots were hybridized overnight at 42°C with the CYP4A1,
GAP, or fibrinogen cDNA probes in 5× SSPE buffer containing 50%
formamide, 5× Denhardt's solution, 1% SDS, and 0.1 mg/ml yeast tRNA.
Blots were washed twice for 30 min in 2× SSC, 0.1% SDS at room
temperature, and three times for 20 min in 0.1× SSC, 0.1% SDS at
55°C (CYP4A1, GAP) or 62°C (fibrinogen).
Data Presentation and Statistical Analysis. The Northern blot assay is semiquantitative only. Therefore, no attempt has been made to express measurements in any absolute units. Values for each experiment were calculated as a percentage of the normalized mean value (arbitrary units) for an appropriate control group. All results are expressed as the mean ± S.E.M. for each group. The numbers of animals used in each experiment are given in the figure legends. The number of observations in some groups was lower than the number of animals due to loss of samples during preparation and/or the assay procedure. Statistical analyses were performed using the Quick Statistica package (StatSoft, Inc., Tulsa, OK). One-way analysis of variance and the Student Newman-Keuls test were used to determine differences among treatment groups. In cases where the variances of the experimental groups were not equivalent, the Mann-Whitney U test was used instead. The null hypothesis was rejected at P < 0.05.
| |
Results |
|---|
|
|
|---|
Specificity of the CYP4A Probes. Figure 2 shows the specificities of the probes used to detect the CYP4A mRNAs, as judged by the known tissue and sex-specific expression of these genes. Thus, all three CYP4A mRNAs are induced by clofibrate. Both CYP4A2 and CYP4A3 are expressed at higher levels in kidney than in liver. CYP4A3 shows no sex specificity, whereas CYP4A2 is male-specific. The CYP4A1 oligonucleotide probe detected only low levels of constitutive expression of this mRNA in both liver and kidney, independent of gender (Fig. 2). Identical results were obtained using the CYP4A1 cDNA probe (Fig. 2). The CYP4A1 cDNA probe was selected for use in subsequent experiments because it was found to give a higher signal to noise ratio in most blots.
|
Role of Hypophagia in LPS and BaSO4 Induction of CYP4A mRNAs. To determine the role, if any, of hypophagia in the induction of hepatic and renal CYP4A mRNAs by LPS, the food intake of saline- and LPS-treated rats was measured at 6-h intervals. The next day, animals in the pair-fed group were given food equal to the amount eaten by the LPS-treated rats during the equivalent time intervals. It was necessary to divide the treatment period into 6-h intervals to approximate the eating pattern of the LPS-treated rats. Otherwise, the pair-fed rats could eat their entire ration in a short period at the beginning of the experiment.
As shown in Table 1, LPS treatment caused a 54% reduction in food intake over the 24-h treatment period. Saline-treated animals ate only 29% of their daily intake during the first 12 h (light cycle) of the experiment and only 3% during the first 6 h. The effects of pair feeding on hepatic and renal CYP4A mRNA expression are compared with those of LPS treatment and starvation in Figs. 3 and 4, respectively. In the liver, pair feeding had no significant effect on CYP4A expression, except for a 72% increase in CYP4A3 mRNA at the 24-h time point (Fig. 3). LPS significantly induced the mRNAs for CYP4A1 and CYP4A3, although the effect of starvation was greater than that of LPS. A significant induction of hepatic CYP4A2 mRNA by LPS was not detected in this experiment, although there was a tendency toward an increase. Similar trends were observed for renal CYP4A expression (Fig. 4). Thus, pair feeding did not induce renal CYP4A1 or CYP4A3 expression, and it only induced CYP4A2 mRNA at the 24-h time point. In contrast, LPS treatment induced CYP4A2 and CYP4A3 at the 12- and 24-h time points. CYP4A1 expression was induced by starvation but not by LPS treatment (Fig. 4).
|
|
|
|
|
Sex- and Strain-Dependence of CYP4A mRNA Induction by LPS and BaSO4. The effects of LPS or BaSO4 treatment on hepatic and renal CYP4A expression were compared in male and female rats of the F344 and S-D strains. Figure 6 shows Northern blots from the livers and kidneys of F344 rats. Figures 7 and 8 contain the quantitative data from this strain. Because the responses of CYP4A mRNAs in livers and kidneys of S-D rats of either sex were very similar to those of F344 rats, only the results for F344 rats are shown. LPS and BaSO4 significantly induced all three CYP4A mRNAs in the livers of F344 male rats (Fig. 7). The effects of LPS or BaSO4 treatment in male S-D rat livers were similar to those in the F344 animals, except that LPS treatment of male S-D rats produced only a trend toward an increase in CYP4A2 mRNA (LPS, 239 ± 32; control, 100 ± 74; P < 0.08) (not shown). LPS treatment failed to induce the expression of any CYP4A mRNA in the livers of female rats of either strain (F344, Fig. 7; S-D, results not shown). BaSO4 treatment produced elevations in CYP4A1 and CYP4A3 expression in female F344 and S-D rats, but these were smaller than the effects seen in the corresponding males (F344, Fig. 7; S-D, results not shown).
|
|
|
| |
Discussion |
|---|
|
|
|---|
Our previous pair-feeding study in the mouse showed that the
induction of renal CYP4A caused by LPS treatment was not caused by
LPS-evoked hypophagia (Barclay et al., 1999
). The results presented here indicate that this is also true of both hepatic and renal CYP4A
induction in the rat. Pair feeding did not significantly elevate
hepatic CYP4A1 and CYP4A2 or renal CYP4A1 and CYP4A3 expression. Although increases in hepatic CYP4A3 (Fig. 3) and renal CYP4A2 were
observed with pair feeding at the 24-h time point, in both cases it can
be seen that LPS treatment induced these mRNAs at the earlier (12-h)
time when there was no effect of pair feeding. Thus, although
LPS-induced hypophagia may produce some effect on CYP4A expression, we
conclude that it is not the major mechanism. We have speculated
previously that induction of CYP4As following LPS treatment is caused
by generation of prostaglandins or leukotrienes during the inflammatory
response, leading to activation of PPAR
(Barclay et al., 1999
).
Treatment of rats with the particulate irritant BaSO4 produces a more profound effect on food intake over the first 24 h than does LPS treatment (21% of control for BaSO4, 46% for LPS; see Tables 1 and 2). BaSO4 treatment, or pair feeding with the BaSO4-treated animals, had similar effects on CYP4A expression in rat liver and kidney (Fig. 5), indicating that the induction of hepatic and renal CYP4As caused by BaSO4 treatment is mainly due to irritant-induced hypophagia. Thus, the threshold for reduced food intake causing a significant induction of CYP4A expression lies between 21% (Table 2, Fig. 5) and 46% (Table 1, Figs. 3 and 4).
Interestingly, although control rats ate only 25 to 29% of their daily
intake in the first 12 h (and only 1-3% in the first 6 h,
Tables 1 and 2), food deprivation during this short period caused
significant induction of hepatic and renal CYP4As (starved animals,
12-h time point, Figs. 3 and 4). Whereas we observed no further
induction over the next 12 h, Kroetz et al. (1998)
reported that
the induction of hepatic CYP4As at 48 h of starvation was more
than double that observed at 24 h. Taken together, these observations suggest that the time course of CYP4A induction caused by
starvation is biphasic, with peaks at 12 and 48 h.
Induction of hepatic CYP4A mRNAs by either LPS or
BaSO4 treatment showed a clear sex dependence in
rats of both strains tested (F344, Fig. 7; S-D, results not
shown). Induction was either absent, or the responses were
significantly smaller, in female rats. Sundseth and Waxman (1992)
reported that the peroxisome proliferator clofibrate (400 mg/kg daily
for 3 days) failed to induce CYP4A3 and CYP4A2 in female rats and that
CYP4A1 was induced to a lesser extent in females than in males. Females
were also less responsive to the induction of peroxisome marker enzymes
than were males (Sundseth and Waxman, 1992
). Thus, the hepatic CYP4A
inducers LPS, BaSO4 (hypophagia), and peroxisome
proliferators share the common characteristic of being
male-specific or male-dominant, indicating that the mechanism of
induction by each of these agents contains a common sex-dependent component. Since hepatic induction of CYP4As by peroxisome
proliferators requires PPAR
(Lee et al., 1995
), our results are
consistent with a role of PPAR
in the hepatic induction of CYP4A by
LPS in the rat, as well.
In contrast to the liver, we did not observe any clear sex dependence
of renal CYP4A induction in the kidney. In S-D rats, we found that LPS
or BaSO4 treatment induced only CYP4A1 mRNA, and
this occurred to the same extent in either sex (not shown). In F344
rats, this effect was male-specific (Fig. 8). In contrast, CYP4A3
expression was induced by LPS treatment in F344 females only. Clearly,
induction of renal CYP4A mRNAs by inflammatory stimuli is of smaller
magnitude than that observed in liver (Fig. 5; compare Figs. 3 and 4, 7
and 8), a characteristic that is shared with peroxisome proliferators
(Sharma et al., 1989
). The small magnitude of the renal effects
undoubtedly contributes to the variability observed in the responses of
individual CYP4As in different experiments (e.g., renal CYP4A2 and 4A3
were significantly induced by LPS in male F344 kidneys in the
experiment in Fig. 4; these effects did not reach significance in the
experiment in Fig. 8). More experiments with much larger numbers of
animals would therefore be needed to determine whether sex and strain differences in renal CYP4A induction exist. The observed induction of
CYP4A1 and CYP4A3 mRNAs in female rat kidneys (F344, Fig. 8; S-D,
results not shown) is consistent with our previous report of a
strong PPAR
-dependent induction of renal CYP4A10 and CYP4A14 mRNAs
in female mice (Barclay et al., 1999
). To our knowledge, the sex
dependence, if any, of renal CYP4A induction by peroxisomal proliferators in rats has not been reported, although the induction of
renal peroxisomal enzymes acyl-CoA oxidase and bifunctional enzyme by
dehydroepiandrosterone showed no marked sex difference (Yamada et al.,
1991
).
In a previous publication, we referred to unpublished data indicating
that hepatic induction of CYP4A mRNAs in male S-D rats by LPS treatment
was absent (CYP4A2) or reduced (CYP4A1, -4A3) compared with that seen
in F344 rats (Sewer et al., 1997
). The present results provide no
evidence for this strain difference suggested by the previous
preliminary study. The effects of LPS and BaSO4
on hepatic CYP4A mRNAs were similar in both strains, except that the
induction of CYP4A2 mRNA by LPS in S-D rats just failed to achieve
statistical significance. This lack of a strain difference is perhaps
not surprising, given that no major strain difference has been reported
in the effects of peroxisome proliferators in rats and that the
available evidence (present study; Barclay et al., 1999
) suggests that
induction of hepatic CYP4As following LPS treatment is
PPAR
-dependent.
In our characterization of the oligonucleotide and cDNA probes used to
measure the CYP4A mRNAs (Fig. 2), the observed sex and tissue
specificities of CYP4A2 and -4A3 expression detected by our probes were
in general agreement with those of other groups (Sundseth and Waxman,
1992
; Helvig et al., 1998
). In contrast, Helvig et al. (1998)
found
high levels of expression of CYP4A1 in female S-D rat kidney using a
SacI-EcoRI cDNA probe, whereas we observed very
low basal expression of CYP4A1 mRNA in kidneys of F344 rats of either
sex. The disparity was not caused by a strain or age difference: we
repeated this experiment using RNA from 8- and 13-week-old S-D rats and
found essentially the same results (not shown) seen in Fig. 2 using
tissues from F344 rats. We obtained the same results using either an
end-labeled oligonucleotide probe or a random primer-labeled cDNA
fragment, both corresponding to a portion of the 3'-untranslated region
of the CYP4A1 mRNA. Helvig et al. (1998)
used the same cDNA fragment,
labeled by nick translation. Therefore, the difference in our findings
is unexplained. However, our results agree with those of Sundseth and
Waxman (1992)
, who used an oligonucleotide probe.
In conclusion, we have shown that the induction of hepatic CYP4A after
treatment of rats with LPS or the particulate irritant BaSO4 is male-specific, consistent with
participation of PPAR
in these responses. We have also demonstrated
that whereas the induction of CYP4A expression caused by
BaSO4 treatment is mainly due to hypophagia, the
induction by LPS treatment is not caused by the reduction in food
intake in these animals.
| |
Footnotes |
|---|
Received May 10, 2000; accepted August 28, 2000.
This work was supported by Grant GM46897 from the National Institute of General Medical Sciences (to E.T.M.) and by a Howard Hughes Predoctoral Fellowship (to M.B.S.).
Send reprint requests to: Edward T. Morgan, Ph.D., Department of Pharmacology, Emory University, Atlanta, GA 30322. E-mail: etmorga{at}bimcore.emory.edu
| |
Abbreviations |
|---|
Abbreviations used are: P450, cytochrome P450; GAP, glyceraldehyde-3-phosphate dehydrogenase; LPS, bacterial lipopolysaccharide; F344, Fischer 344; PPAR, peroxisome proliferator-activated receptor; S-D, Sprague-Dawley; SSC, standard saline citrate.
| |
References |
|---|
|
|
|---|
isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators.
Mol Cell Biol
15:
3012-3022[Abstract].This article has been cited by other articles:
![]() |
T. A. Richardson, M. Sherman, L. Antonovic, S. S. Kardar, H. W. Strobel, D. Kalman, and E. T. Morgan HEPATIC AND RENAL CYTOCHROME P450 GENE REGULATION DURING CITROBACTER RODENTIUM INFECTION IN WILD-TYPE AND TOLL-LIKE RECEPTOR 4 MUTANT MICE Drug Metab. Dispos., March 1, 2006; 34(3): 354 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Richardson, M. Sherman, D. Kalman, and E. T. Morgan EXPRESSION OF UDP-GLUCURONOSYLTRANSFERASE ISOFORM mRNAS DURING INFLAMMATION AND INFECTION IN MOUSE LIVER AND KIDNEY Drug Metab. Dispos., March 1, 2006; 34(3): 351 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Richardson and E. T. Morgan Hepatic Cytochrome P450 Gene Regulation during Endotoxin-Induced Inflammation in Nuclear Receptor Knockout Mice J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 703 - 709. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nisar, C. S. Lane, A. F. Wilderspin, K. J. Welham, W. J. Griffiths, and L. H. Patterson A PROTEOMIC APPROACH TO THE IDENTIFICATION OF CYTOCHROME P450 ISOFORMS IN MALE AND FEMALE RAT LIVER BY NANOSCALE LIQUID CHROMATOGRAPHY-ELECTROSPRAY IONIZATION-TANDEM MASS SPECTROMETRY Drug Metab. Dispos., April 1, 2004; 32(4): 382 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kalsotra, S. Anakk, C. L. Boehme, and H. W. Strobel Sexual Dimorphism and Tissue Specificity in the Expression of CYP4F Forms in Sprague Dawley Rats Drug Metab. Dispos., September 1, 2002; 30(9): 1022 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Morgan Regulation of Cytochrome P450 by Inflammatory Mediators: Why and How? Drug Metab. Dispos., March 1, 2001; 29(3): 207 - 212. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||